The authors investigated the effect of Trastuzumab deruxtecan on the expression of HLA class I and CXCL9/10/11, T cell chemoattractants, in HER2-positive human gastric cancer cells.
[Scientific Reports]
7992332
{7992332:G4DQYSWW}
apa
50
1
165871
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
